A U.S. and Canada channel. MilliporeSigma's BioReliance® services is a global offering of biologics safety testing and product characterization
Rockville, MD - USA
Joined June 2009
- Tweets987
- Following602
- Followers907
- Likes21
Adenoviral vector products require RCA testing, which can be a bottleneck for lot release. Our solution? Join this webinar to learn how a new rapid RCA assay in development can help expedite release testing. Register now here, ms.spr.ly/6013whFRc
ALT Find out how you can accelerate your lot release, live tomorrow!
We love when math tells the story. Trust our expert partners to perform your IND and BLA-enabling studies. It’s not too late to book for early 2022! rb.gy/scoszu #bioreliance #viralclearance
BioReliance retweeted
Congrats to @MilliporeSigma for being a winner in the Analytical/Test category for its Blazar™ Platform. MilliporeSigma’s innovative Blazar™ platform reduces turn-around-time from up to 63 days to ten days, while testing for 25 additional and emerging viral risks. #RD100
We’re honored to be the Interphex Awards 2020 Editor’s Choice recipient for the MilliporeSigma BioReliance® Blazar™ Platform. Congratulations to our team of innovators! #INTERPHEX #Bioprocessing #pharma #bio #PharmaceuticalProcessing
ALT Interphex Awards 2020 Editor’s Choice - BioReliance® Blazar™ Platform
The COVID-19 pandemic has highlighted concerns of animal virus contamination of raw materials. Dr. Danny Galbraith shares insights to protect your process. #COVID19
Detecting the next permutations of COVID-19. Dr. Danny Galbraith discusses methods to predict virus mutations and recombination. . #COVID19 #MilliporeSigma #Biopharma
We’re engaging the biopharma community to prioritize biosafety testing. Just as we did during Zika, SARS, and Ebola outbreaks, we’re here to support vaccine and therapeutic developers & mfrs. Contact us ms.spr.ly/6012TdGUM @MilliporeSigma #covid19 #biopharma #vaccines #DCVMN
We’re here to support vaccine and therapeutic developers & mfrs to deliver therapies. Our facilities are operating and we’re prioritizing biosafety testing. Contact us. ms.spr.ly/6013TdGot @MilliporeSigma #covid19 #biopharma #vaccines #DCVMN
Planning your trip to Society of Toxicology? Meet us at booth #631 and don't miss these powerful poster presentations. #2020sot ms.spr.ly/6014TblzY
We've got big news at SOT in Anaheim this year. Find out at booth #631. #2020sot ms.spr.ly/6014Tboxr
What if you have a positive in vitro assay? Don't panic. Our study directors are @ booth 631 at Society of Toxicology. #2020sot ms.spr.ly/6012TbcLq
Join us at #ACTOX2019 as we tackle the tough questions at booth 304. Nov 20th Dr. Kulkarni presents on GeneTox Assays for Impurities Testing ms.spr.ly/6015TTn9f
Join us at @ESGCT in Barcelona this week as Sarah Sheridan and Eva Fong present Rapid Biosafety Test Methods & Lentivirus Production in Suspension. #esgct19 #MilliporeSigma #bioreliance #genetherapy
MilliporeSigma launches CAN FlowScreen services for detection of multiple biomarkers in a single assay:goo.gl/S9Qs5h
Register for Dr. Wisher’s Reg Guidance & Advice on the QC of Adv. Therapy Medicinal Products Workshop, 10/19 @ESGCT bit.ly/2dEiQM2
Marian McKee of @BioReliance talks to @BioPharmIntl about how new therapies are challenging #microbiology testing: goo.gl/tIhfny
Looking forward to a productive 2 days of discussions on viral safety and raw materials. #viralsafety
Doug Chambers describes what makes a good #dataintegrity strategy, from training to implementation, in @ADCReview: goo.gl/D7Q6Oa
Martha Rook, Head of Novel Therapies, & @PharmaProEditor on syncing science, tech & mfg: goo.gl/4yXxP3 #genetherapy #singleuse
Our team is about to board the plane to #Shanghai for the 5th Annual Cell Line Development & Engineering Asia! ow.ly/kJ3x300bpev